GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 24 filers reported holding GAIN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $689,000 | +665.6% | 210,000 | +947.6% | 0.00% | – |
| Q2 2023 | $90,000 | -52.1% | 20,046 | -48.6% | 0.00% | – |
| Q1 2023 | $188,000 | +54.1% | 39,000 | 0.0% | 0.00% | – |
| Q4 2022 | $122,000 | -3.9% | 39,000 | -0.2% | 0.00% | – |
| Q3 2022 | $127,000 | -9.3% | 39,086 | +0.2% | 0.00% | – |
| Q2 2022 | $140,000 | -31.7% | 39,000 | -22.0% | 0.00% | – |
| Q1 2022 | $205,000 | +259.6% | 50,000 | +373.5% | 0.00% | – |
| Q4 2021 | $57,000 | – | 10,560 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 30,293 | $303,000 | 0.42% |
| Greenlight Capital | 546,560 | $5,466,000 | 0.34% |
| CM Management, LLC | 10,000 | $100,000 | 0.07% |
| Granite Point Capital Management, L.P. | 155,709 | $1,559,000 | 0.06% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $581,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 50,000 | $501,000 | 0.01% |
| Banque Cantonale Vaudoise | 3,000 | $30,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 23,878 | $239,000 | 0.00% |
| MORGAN STANLEY | 800 | $8,000 | 0.00% |
| BlackRock Inc. | 11,659 | $116,000 | 0.00% |